Biotechnology

The Results of Phase II Clinical Study of KN046 in Combination with Nab-paclitaxel in TNBC were Published in Nature Communications

SUZHOU, China, Feb. 6, 2024 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) announced that the phase Ⅱclinical research results of anti- PD-L1/CTLA-4 bispecific antibody KN046 in combination with nab-paclitaxel as first-line treatment in advanced triple-negative breast cancer (TNBC) were ...

2024-02-07 09:50 2939

SMC Laboratories Reveals Innovative STAM™-HCC/IO+ Mouse for Identifying and Developing Novel Therapeutic Drugs for Liver Cancer, Blazing a Trail in the Immuno-Oncology Field

TOKYO, Feb. 7, 2024 /PRNewswire/ -- SMC Laboratories, Inc. ("SMC Laboratories"), a non-clinical contract research organization (CRO) that provides consulting and contract services for pharmacology studies utilizing technology and know-how related to Metabolic dysfunction associated steatohepatit...

2024-02-07 02:00 2573

SMC Laboratories Reveals Innovative STAM™-HCC/IO+ Mouse for Identifying and Developing Novel Therapeutic Drugs for Liver Cancer, Blazing a Trail in the Immuno-Oncology Field

TOKYO, Feb. 7, 2024 /PRNewswire/ -- SMC Laboratories, Inc. ("SMC Laboratories"), a non-clinical contract research organization (CRO) that provides consulting and contract services for pharmacology studies utilizing technology and know-how related toMetabolic dysfunction associated steatohepatiti...

2024-02-07 02:00 2749

Nordic Bioscience to make its precision medicine biomarker PRO-C3 available in China for research use only (RUO) in the first quarter of 2024.

HERLEV, Denmark, Feb. 6, 2024 /PRNewswire/ -- Nordic Bioscience, a leading biomarker company, today announced that the company's extracellular matrix (ECM) biomarker, PRO-C3 (nordicPRO-C3™) will be available as a research use only (RUO) product inChina at LabCorp. All testing outside China contin...

2024-02-06 06:30 2696

Innovent Announces Retirement of CFO and Appointment of New CFO

ROCKVILLE, Md. and SUZHOU, China, Feb. 5, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("c") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, autoimmune, metabolic, ophthalmology and other ...

2024-02-05 16:45 4278

Singapore Bio-Tech Company Bio Ark Global Partners Bandung's State-Owned Enterprise, Signs MOU To Be Awarded 4000ha Of Land In Pemalang

~ Redefining Agriculture is Bio Ark Global's Vision for Indonesia ~ SINGAPORE, Feb. 5, 2024 /PRNewswire/ -- Bio Ark Global Pte Ltd has announced that a Memorandum of Understanding (MOU) has been formalised in Bandung Indonesia to mark its expansion inSoutheast Asi...

2024-02-05 15:12 2312

Producing More with Less, While Restoring More: Bayer Crop Science China Releases Regenerative Agriculture Theme Video

BEIJING, Feb. 4, 2024 /PRNewswire/ -- Producing More with Less, While Restoring More,is the message Bayer Crop Science conveys to Chinese farmers through the recently released regenerative agriculture theme video. Regenerative agriculture is a sustainable agricultural model focusing on improving ...

2024-02-04 14:00 3538

World Cancer Day 2024: RemeGen Announces Three Significant Developments in the Global Fight Against Cancer, Narrowing the Care Gap

YANTAI, China, Feb. 2, 2024 /PRNewswire/ -- RemeGen Co. Ltd. ("RemeGen" or "the Company") (9995.HK, 688331.SH), a commercial-stage biotechnology company, with a mission that is closely aligned with the Close the Care Gap theme of World Cancer Day 2024 which falls on Febru...

2024-02-02 21:30 3466

Fapon and Bio Farma Sign MOU for Medical Innovations

DONGGUAN, China, Feb. 2, 2024 /PRNewswire/ -- On February 1, 2024, Fapon, a global leading life science company, andBio Farma, a state-owned pharmaceutical holding company inIndonesia specializing in vaccines, life science products, and other pharmaceuticals, signed a memorandum of understanding ...

2024-02-02 16:30 3651

Biosyngen Announces FDA Fast Track Designation for BST02 in Treatment of Liver Cancer

SINGAPORE, Feb. 1, 2024 /PRNewswire/ -- Biosyngen is proud to announce that its latest groundbreaking product, BST02, has been granted Fast Track Designation (FTD) by the U.S. Food and Drug Administration (FDA) for the treatment of all types of liver cancer, including hepatocellular carcinoma and...

2024-02-01 17:41 3246

EMA Aesthetics Announces a Long-Term Strategic and Equity Partnership with ROHTO Pharmaceutical, Signalling ROHTO's Acceleration into the Global Aesthetics Market

DUBLIN, Feb. 1, 2024 /PRNewswire/ -- EMA Aesthetics (www.emaaesthetics.com ) a global aesthetics company headquartered inDublin, is delighted to announce a strategic and equity partnership with ROHTO Pharmaceutical ( www.rohto.co.jp/global

2024-02-01 16:00 3825

SoniVie announces enrollment completion in the REDUCED-1 pilot study with TIVUS™ Ultra-Sound Renal Denervation

SoniVie announces enrollment completion in the REDUCED-1 pilot study TEL AVIV, Israel, Feb. 1, 2024 /PRNewswire/ -- SoniVie , an Israeli company developing a novel, proprietary Therapeutic Intra-Vascular Ultrasound (TIVUSTM) System to treat a variety of hypertensive diso...

2024-02-01 01:52 2804

21ST.BIO OPENS A MORE SUSTAINABLE AVENUE FOR INDUSTRIAL SCALE DAIRY PROTEIN PRODUCTION

* Global bioproduction leader 21st.BIO today announced it is now granting access to its precision fermentation technology platform to food and ingredient manufacturers, enabling sustainable production of dairy proteins at competitive cost.            * Access to 21st.BIO's technology represen...

2024-01-31 16:47 1894

GMP cell CDMO I Peace, Inc. obtains accreditation as ISO 17025: 2017 compliant

Starts undertaking quality evaluation and characterization of iPSCs in accordance with ISO standards PALO ALTO, Calif. , Jan. 30, 2024 /PRNewswire/ -- Leading GMP cell CDMO I Peace, Inc. (https://www.ipeace.com ), specializing in induced pluripotent stem cells (iPSCs) an...

2024-01-31 05:46 2890

The Biotech Accelerator Unicorn Program: A Unique Collaboration between CKGSB and the UC San Diego Rady School of Management

SAN DIEGO, Jan. 30, 2024 /PRNewswire/ -- Cheung Kong Graduate School of Business (CKGSB) andUniversity of California San Diego (UC San Diego) Rady School of Management are proud to announce the launch of the Biotech Accelerator Unicorn Program, a pioneering joint program specifically designed to...

2024-01-30 22:25 2798

Angel Yeast's 2024 New Year's Resolutions: Advancing Development through Technological Innovation

SHANGHAI, Jan. 29, 2024 /PRNewswire/ -- Angel Yeast (SH600298), the world's leading yeast manufacturer, is excited to share its resolutions for 2024. Building upon the achievements of 2023 and upholding high standards across various indicators,Angel Yeast is dedicated ...

2024-01-29 20:44 4261

deCODE genetics: A sequence variant that increases risk of pregnancy loss

REYKJAVIK, Iceland, Jan. 29, 2024 /PRNewswire/ -- Scientists at deCODE genetics, a subsidiary of Amgen, and their collaborators from Iceland, Denmark, and theUSA published a study today in Nature Structural & Molecular Biology titled "Variant in the synaptonemal complex protein SYCE2 associates ...

2024-01-29 18:00 3431

Inside information made public: Nanoform Announces Important Milestone with Promising Clinical Results for Patient-Centric Nanotechnology-Enhanced Enzalutamide

THIS PRESS RELEASE CONTAINS INFORMATION THAT NANOFORM IS OBLIGED TO MAKE PUBLIC PURSUANT TO THE EU MARKET ABUSE REGULATION. THE INFORMATION WAS SENT FOR PUBLICATION THROUGH THE AGENCY OF THE CONTACT PERSONS SET OUT BELOW, ONJANUARY 26, 2024, AT 11:20 FINNISH TIME / 10:20 SWEDISH TIME. HELSINKI, ...

2024-01-26 20:08 2347

AbbVie Expands Biologics Manufacturing Capacity with a $223 Million Investment in Singapore Manufacturing Site

* US$223 million expansion will add biologics capacity to AbbVie manufacturing network * Singapore manufacturing site to grow to more than 500 employees following expansion * Construction will commence immediately with facilities becoming operational in 2026 SINGAPORE, Jan. 26, 2024 /PRNews...

2024-01-26 08:30 6836

Ceva Santé Animale acquires Scout Bio, paving the way for groundbreaking innovations in pet therapeutics

LIBOURNE, France, Jan. 26, 2024 /PRNewswire/ -- Ceva Santé Animale (Ceva), the #5 animal health company present in 110 countries worldwide, announcesthe strategic acquisition of Scout Bio, a pioneer in biotechnology focused on cutting-edge therapies for pets. The move represents a significant lea...

2024-01-26 06:00 4600
1 ... 76777879808182 ... 185